ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

ENLV Enlivex Therapeutics Ltd

1.36
0.0101 (0.75%)
31 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Enlivex Therapeutics Ltd ENLV NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.0101 0.75% 1.36 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.35 1.3082 1.36 1.36 1.3499
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/5/202415:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/5/202415:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/5/202415:15GLOBEEnlivex Therapeutics Closes up to $15 Million Registered..
28/5/202407:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202407:12GLOBEEnlivex Therapeutics Announces up to $15 Million Registered..
29/4/202407:00GLOBEEnlivex CEO Issues Letter to Shareholders – Perspectives on..
22/4/202407:00GLOBEEnlivex Announces Dosing of First Two Patients in its..
16/4/202415:55APSYet Another Biotech Stock Has Found Success During Tuesday's..
16/4/202406:50GLOBEEnlivex Announces Authorization from the Danish Regulatory..
11/4/202413:58GLOBEEnlivex to Host Webcast on April 12, 2024 at 8:30 a.m...
11/4/202407:05GLOBEEnlivex Announces Topline Results of Its Phase II Trial..
07/2/202407:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/2/202407:00GLOBEEnlivex Announces Issuance of New U.S. Patent Covering..
22/1/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202407:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202407:00GLOBEEnlivex Receives IMOH Regulatory Authorization for the..
20/12/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/11/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/9/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/9/202315:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/8/202307:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/7/202307:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

Delayed Upgrade Clock